Document is current
Any future updates will be listed below
-
Authors
Soppe, Sarah E.
Peacock Hinton, Sharon
Halula, Jamie C.
Lund, Jennifer L.
Baggett, Chris D.
Pruitt, Sandi L.
Mullins, Megan A.
Dillon, Ellis C.
Barclay, Matthew E.
Thompson, Matthew
Pettit, Nicholas
Lyratzopoulos, Georgios
Thompson, Caroline A.
-
Funding
Funding for this research was provided by:
National Cancer Institute (R01-CA-264176, R01-CA-264176, R01-CA-264176, R01-CA-264176)
Susan G. Komen (TREND21686258)
Cancer Research UK International Alliance for Cancer Early Detection (EDDAPA-2022/100002)
American Cancer Society (CSDG-23-1025372-01-CPSH)
- License Information
-
More Information
Article History
Received: 26 June 2024
Accepted: 18 December 2024
First Online: 9 January 2025
Declarations
:
: Sandi Pruitt reports consulting fees from Pfizer and Gilead unrelated to the current study; there are no other potential conflicts to report for other authors for the past 3 years.
